PEPTIDREAM
PeptiDream is a biopharmaceutical company founded in 2006 employing our proprietary Peptide Discovery Platform System (PDPS), a state-of-the-art highly versatile discovery platform which enables the production of highly diverse (trillions) non-standard peptide libraries with high efficiency, for the identification of highly potent and selective hit candidates, which then can be developed into peptide-based, small molecule-based, or peptide-drug-conjugate-based therapeutics.
PEPTIDREAM
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2006-01-01
Status:
Active
Contact:
81-44-270-1300
Total Funding:
374 M JPY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Global Site Tag Euro JsDelivr
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
IntraBio
IntraBio is a biopharmaceutical company.
Samsung Bioepis
Samsung Bioepis is a biopharmaceutical company.
Saol Therapeutics
Saol Therapeutics is a biotech pharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-06-19 | PharmaDesign | PharmaDesign acquired by Peptidream | N/A |
Investors List
Novartis Pharma
Novartis Pharma investment in Venture Round - Peptidream
Summit Pharmaceuticals International
Summit Pharmaceuticals International investment in Seed Round - Peptidream
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Seed Round - Peptidream
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-11-14 | Kleo | Peptidream investment in Series B - Kleo | 21 M USD |
| 2018-08-09 | Modulus Discovery | Peptidream investment in Series A - Modulus Discovery | 800 M JPY |
| 2018-04-18 | PeptiStar | Peptidream investment in Corporate Round - PeptiStar | 20 B JPY |
More informations about "Peptidream"
Company Info / Access｜PEPTIDREAM INC ペプチドリーム株式会社
PeptiDream Inc. (Tokyo Stock Exchange Prime Market 4587) is leading the translation of …See details»
Management Team｜PEPTIDREAM INC ペプチドリー …
Co-founder of PeptiDream, after working as Associate Professor at University of Tokyo CSO, Head of R&D until 2017 CEO at PeptiDream 2017 to current Ph.D. in Biochemistry from Dartmouth Medical School Director, COO Keiichi Masuya. …See details»
Peptidream - Crunchbase Investor Profile & Investments
PeptiDream is a biopharmaceutical company founded in 2006 employing our proprietary Peptide Discovery Platform System (PDPS), a state-of-the-art …See details»
Astellas and PeptiDream Enter into Research ... - Business Wire
Jul 25, 2023 PeptiDream also markets and sells a number of radiopharmaceutical and …See details»
Astellas and PeptiDream enter into collaboration to develop
On July 26, 2023, Astellas and PeptiDream announced that they have entered into a research …See details»
How a Japanese Biotech Company Is Innovating Drug …
Jan 24, 2020 PeptiDream is now a $7 billion company and is also a founding investor in a contract manufacturing company, PeptiStar. Collaboration with other companies is crucial, says PeptiStar CEO Kameyama ...See details»
PeptiDream Announces Collaboration and License …
Sep 20, 2023 PeptiDream has an extensive global network of discovery and development partners driving the development and commercialization of a broad and diversified pipeline of investigational therapeutics.See details»
Corporate Philosophy｜PEPTIDREAM INC ペプチドリーム株式会社
Our culture is anchored in the belief that every employee has the ability to be exceptional. We …See details»
PeptiDream Announces Expansion of Peptide …
KAWASAKI, Japan, April 30, 2024--PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President and CEO: Patrick C. Reid, hereinafter "PeptiDream") (Tokyo: 4587) today ...See details»
PeptiDream Inc. - J-Startup
PeptiDream is a biopharmaceutical company that employs its proprietary Peptide Discovery Platform System (PDPS) Technology, a revolutionary next-generation hit finding platform for new drugs. ... New Energy and Industrial Technology …See details»
PeptiDream Inc Company Profile - GlobalData
PeptiDream Inc (PeptiDream) is a biopharmaceutical company that discovers and develops …See details»
Peptidream | Company Overview & News - Forbes
PeptiDream Inc. engages in the biopharmaceutical business that includes research and …See details»
Our people｜PEPTIDREAM INC ペプチドリーム株式会社
He joined PeptiDream in 2020 and became Senior Researcher in 2022. Question 01. ... The …See details»
Novartis pays PeptiDream $180M as radiopharma big bang …
Apr 30, 2024 The biotech partnered with PeptiDream in 2020 to access peptide compounds …See details»
PeptiDream - Devex
PeptiDream Inc. is a public (Tokyo Stock Exchange 1st Section 4587) biopharmaceutical …See details»
Novartis and PeptiDream expand peptide discovery deal
May 1, 2024 Novartis and Japanese biopharmaceutical company PeptiDream have expanded …See details»
CEO Message｜PEPTIDREAM INC ペプチドリーム株式会社
In the area of sustainability, we continued to make significant progress, highlighted by …See details»
Peptidream - Contacts, Employees, Board Members, Advisors
Peptidream has 5 current employee profiles, including Executive Vice President Director – …See details»
Sustainability Report 2022 - ペプチドリーム株式会社
Integrate and embed these efforts within our organization and into our business. 01 CEO …See details»